PSTV Plus Therapeutics, Inc.
Plus Therapeutics, Inc. is a late stage cell therapy company, which engages in the development of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions. It offers the Cytori Nanomedicine, Cytori Cell Therapy, and other clinical trials. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Austin, TX.
$2.23
As of 03/04/2021 IEX book CBOE book
Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Biotechnology
USA
USA
07/29/2019
9,166,902
1,728,859
$22,000,565
0.00%
SEC Edgar Online
10-Q
10-K
72941H400
US72941H4002
BK80SZ2
Common stocks
Micro cap
Health Care
Biotechnology
USA
USA
07/29/2019
9,166,902
1,728,859
$22,000,565
0.00%
SEC Edgar Online
10-Q
10-K
72941H400
US72941H4002
BK80SZ2
Valuation (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-7.52
42.86
72.61
-271.89%
-2,719.80%
42.86
72.61
-271.89%
-2,719.80%